BIOTRICITY INC (BTCY)
US09074H2031 - Common Stock
Biotricity receives Health Canada clearance for Biotres (NASDAQ:BTCY)
Biotricity (BTCY) receives approval from Health Canada for their flagship product, Biotres – a three-channel continuous ECG cardiac monitoring device.
Biotricity reports preliminary Q3 results (NASDAQ:BTCY)
Biotricity expects to achieve significant improvements in Q3 with higher gross margins and reduced operating expenses.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.
Biotricity posts $14M revenue run rate in August (NASDAQ:BTCY)
Biotricity (BTCY) Wednesday said that the Healthcare technology company achieved a record $14 million annualized revenue run rate in August.The company added that the last ARR extended...
Biotricity sees record Q1-FY2024 recurring revenue growth (NASDAQ:BTCY)
Biotricity Inc (BTCY) on Friday said company to report robust performance improvements in its operating metrics for the first fiscal quarter ended June 30, 2023.Record Q1-FY2024...
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...
Biotricity FQ1'24 revenue estimated to rise by ~40% (NASDAQ:BTCY)
Technology-as-a-Service company Biotricity (BTCY) said on Thursday that its FQ1'24 revenue is estimated to rise by ~40% Y/Y.
Biotricity announces reverse stock split (NASDAQ:BTCY)
Biotricity Holdings (BTCY) said on Friday that it will effect a reverse stock split of it common stock, effective after markets open on July 3.BTCY shares up +2.1%. "At the effective...